CHICAGO: Additional reports of patients with long Covid who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test the medicine for the debilitating condition, U.S. researchers said on Thursday.Three new case studies follow earlier reports of long Covid patients who experienced relief of their symptoms after taking the treatment, which is currently only authorized for high-risk people early after onset of Covid symptoms.As many as 30% of people infected by the coronavirus are believed to develop long Covid, a condition that can last for several months with symptoms including fatigue, rapid heartbeat, shortness of breath, chron
Hence then, the article about evidence mounts for need to study pfizer s paxlovid for long covid researchers say was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Evidence mounts for need to study Pfizer’s Paxlovid for long Covid, researchers say )